AstraZeneca’s IMFINZI improves lung cancer survival
10th March 2023 Uncategorised 0Positive results emerge from AEGEAN phase 3 trial for patients with resectable non-small cell lung cancer More: AstraZeneca’s IMFINZI improves lung cancer survival Source: News
read more